z-logo
Premium
KHSV − EBV − post‐transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma?
Author(s) -
Lambe Jennifer S.,
Oble Darryl A.,
Nandula Subhadra V.,
Sevilla Deborah W.,
Colovai Adriana I.,
Mansukhani Mahesh,
Chari Ajai,
Murty Vundavalli V.,
Alobeid Bachir,
Bhagat Govind
Publication year - 2009
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.892
Subject(s) - primary effusion lymphoma , lymphoma , medicine , plasmablastic lymphoma , pathology , epstein–barr virus , effusion , virus , pleural effusion , virology , surgery
Primary effusion lymphoma (PEL) is a rare type of B‐cell non‐Hodgkin lymphoma (NHL), which predominantly occurs in HIV‐infected individuals, and is pathogenetically linked with Kaposi sarcoma (KS)‐associated herpes virus/human herpes virus‐8 (KSHV/HHV‐8) infection with or without evidence of Epstein–Barr virus (EBV) co‐infection. Although uncommon, PELs have been reported in immunocompetent patients and recipients of solid organ allografts. Rare cases of KSHV − EBV + post‐transplant effusion lymphomas resembling PEL have also been described, as have KSHV − EBV − effusion lymphomas, the latter including those arising in individuals with chronic liver disease. We report a unique KSHV − EBV − post‐transplant effusion lymphoma associated with serum paraproteins, occurring in an HIV − individual, which had cytologic features and phenotype similar to PEL, and displayed a complex karyotype including isochromosome 12p and translocation t(8;22), resulting in rearrangement of c‐MYC . Copyright © 2009 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom